Ainos (OTCMKTS:AIMD) Trading 0.3% Higher – Should You Buy?

Ainos, Inc. (OTCMKTS:AIMD)’s stock price was up 0.3% during trading on Tuesday . The company traded as high as $0.48 and last traded at $0.46. Approximately 88,996 shares were traded during trading, a decline of 90% from the average daily volume of 860,914 shares. The stock had previously closed at $0.45.

Ainos Stock Up 9.6 %

The company has a market capitalization of $7.04 million, a P/E ratio of -0.57 and a beta of 1.42. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.92 and a quick ratio of 1.45. The stock has a 50-day moving average price of $0.46 and a 200-day moving average price of $0.58.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.